SeaStar Medical Holding Corporation cash flow to debt ratio of -2.59K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

SeaStar Medical Holding Corporation's free cash flow has increased -15.04% from $-16.01M last year to $-13.60M, signaling increasing performance

SeaStar Medical Holding Corporation's debt to equity ratio is 0.05, which means that the company's assets are healthy financed, signaling financial stability.

SeaStar Medical Holding Corporation's debt has increased relative to shareholder equity from -0.26 last year to 0.05 today, signaling weakened financials

SeaStar Medical Holding Corporation has a net cash position, so leverage is healthy.

SeaStar Medical Holding Corporation's interest coverage ratio is -36.67, which means that the company struggles to meet interest obligations, signaling financial risk.

SeaStar Medical Holding Corporation's profit margin has increased (-95.49%) in the last year from -18.39K% to -828.62%, signaling increasing performance

SeaStar Medical Holding Corporation's short-term assets of $13.58M exceed its short-term liabilities of $3.74M

SeaStar Medical Holding Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

SeaStar Medical Holding Corporation's return on equity of -146.29%, is lower than 15.00%, indicating bad performance

SeaStar Medical Holding Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

SeaStar Medical Holding Corporation had positive net income in only 0 out of 5 years, indicating unstable earnings

SeaStar Medical Holding Corporation has negative free cash flow, indicating the company is burning cash rather than generating it

SeaStar Medical Holding Corporation has negative free cash flow, indicating cash burn

SeaStar Medical Holding Corporation's yearly earnings has increased -51.07% since last year from $-24.83M to $-12.15M, signaling increasing performance

SeaStar Medical Holding Corporation's yearly revenue has increased 814.07% since last year from $135.00K to $1.23M, signaling increasing performance

ROIC -156.34% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

SeaStar Medical Holding Corporation has insufficient revenue history to calculate 3-year revenue CAGR.

SeaStar Medical Holding Corporation had revenue growth in 5 out of 5 years, indicating consistent revenue performance

SeaStar Medical Holding Corporation had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

SeaStar Medical Holding Corporation has insufficient data to evaluate this check.

SeaStar Medical Holding Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

SeaStar Medical Holding Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

SeaStar Medical Holding Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable

SeaStar Medical Holding Corporation has insufficient data to evaluate this check.

SeaStar Medical Holding Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

SeaStar Medical Holding Corporation has a price-to-book ratio of 19.76x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

SeaStar Medical Holding Corporation has a price-to-sales ratio of 100.82x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue